I know others may want to add, but I'll start just for a little clarity.
There has been a focus on products available in the pharmacy, but I think you've also heard my colleagues say that precursors are being imported. While there are products available in the pharmacy, they are there for legitimate purposes and we do have to keep that in mind as well.
For the most part, many of those products may not even fall within the regulatory scheme because of the quantity in the package. When we are putting a precursor on the list for control, we look at the legitimate purpose as well. Some of those packages that you may see in pharmacies technically may not even be on the precursor control list because of the amount in that package.
I think my colleagues were saying that when it comes to precursors larger volumes are being used that are coming in through other sources.
I'll let my colleagues with enforcement add if they wish.